Labels The Issue For Viatris Again As It Recalls Insulin Glargine Biosimilar

Bernstein: Recall Could ‘Spell Problem’ For Biocon-Manufactured Product

 
• By Dean Rudge
  
Vieriu Adrian/Alamy Stock Photo
Will the FDA take an interest in Viatris' latest recall? • Source: Alamy (Vieriu Adrian / Alamy Stock Phot/Alamy Stock Photo)

More from Biosimilars

More from Products